• ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass
• Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta
• Anesthetic management of ventricular-peritoneal shunt implantation in osteogenesis imperfecta type IIB: A case report
• Identification of a COL1A2 mutation with a deletion spanning coding and intronic sequence in exon 19 and intron 19 in a fetus with osteogenesis imperfecta type II
• Mutation Analysis of COL1A1 and COL1A2 in Fetuses with Osteogenesis Imperfecta Type II/III
• Osteogenesis imperfecta type II: prenatal diagnosis and association with increased nuchal translucency and hypoechogenicity of the cranium
• Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research